Eminem Joins Kendrick Lamar With Multiple Top 10 Bestsellers
Eminem stands out from so many other rappers thanks to his ability to continuously sell music from his catalog, and not just see it perform well on streaming platforms. He demonstrates that ability again this week, as one of his singles returns to a Billboard list focused solely on pure purchases, and it joins one of his all-time classics in doing so. The rapper matches one of the most exciting superstars in his chosen field today as he doubles up on the tally.
"Shake That," Eminem's collaboration with Nate Dogg, returns to the R&B/Hip-Hop Digital Song Sales chart this week. The cut barely manages to reenter the ranking of the bestselling tunes that can be classified as R&B, rap, or hip-hop in the U.S., landing in last place. "Shake That" joins "Lose Yourself," which lifts one space to No. 7.
As "Shake That" returns, Eminem joins Kendrick Lamar as the only two musicians to occupy more than one space on the R&B/Hip-Hop Digital Song Sales list. Lamar claims twice as many current wins as Eminem, with four current smashes.
Lamar also manages to rank higher than Eminem this period – though both of the latter musician's current bestsellers are much, much older than Lamar's. His tunes "Luther" with SZA, "Not Like Us," and "Put TV Off" with Lefty Gunplay and 'Squabble Up' appear at Nos. 4, 6, 9, and 11, respectively.
A number of other hip-hop powerhouses manage to remain on the R&B/Hip-Hop Digital Song Sales chart as well, but at the moment, none fill more than a single space. "Anxiety" by Doechii leads for its fourth frame, which represents the entirety of its time on the roster.
Drake's former No. 1 "Nokia" dips to third place, landing just ahead of Lamar's highest-rising success. Several other well-known figures like The Weeknd, Playboi Carti, and Pharrell Williams also take up space with former champions.
"Shake That" was released decades ago, but has recently surged in popularity after going viral. The tune peaked at No. 8 earlier this month and is one of Eminem's 69 top 10 hits on the tally. "Lose Yourself," which has now spent 468 frames somewhere on this roster, has somehow only ever peaked at No. 2.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 minutes ago
- Yahoo
Rascal Flatts is coming to Bossier City in 2026. When can you get your tickets?
Are you ready for a night of country music from the early 2000s? Well, Rascal Flatts is coming to Bossier City in early 2026. Brookshire Grocery Arena announced Wednesday that Rascal Flatts will be coming Feb. 20. Rascal Flatts is a country music band that formed in 1999 and has 16 No. 1 hits on the Billboard Hot Country Songs chart. This visit is part of the band's "Life is A Highway" tour and will feature special guest such as Chris Lane and Lauren Alaina. Tickets will be available for purchase at 10 a.m. Friday, Aug. 15, at b1BANK Box Office at Brookshire Grocery Arena and at More: Lainey Wilson is coming to Bossier City. Check out when Makenzie Boucher is a reporter with the Shreveport Times. Contact her at mboucher@ This article originally appeared on Shreveport Times: Check out when to get Rascal Flatts tickets in Bossier City 2026
Yahoo
6 minutes ago
- Yahoo
Medical Tubing Market worth $18.41 billion by 2030, at a CAGR of 8.0%, says MarketsandMarkets™
Delray Beach, FL, Aug. 15, 2025 (GLOBE NEWSWIRE) -- The Medical Tubing Market is projected to reach USD 18.41 billion by 2030 from USD 12.53 billion in 2025, at a CAGR of 8.0% during the forecast period. The market for medical tubing is expanding swiftly due to growing worldwide geriatric population, susceptible to chronic conditions such as cardiovascular disorders and kidney failure, propelling demand for medical tubing across markets like catheters, dialysis, and fluid management. Further, growing popularity for less invasive treatments like endoscopy and angioplasty, with their need for flexible and strong tubing, is propelling market growth. Technological advances in extrusion provide high-quality tubing with improved kink resistance, tensile strength, and flexibility. Breakthroughs in material technology, e.g., silicone, polyurethane, and thermoplastic elastomers, enable enhanced performance for numerous applications including drug delivery and respiratory treatment. Additionally, growth in emerging markets in healthcare infrastructure, higher spending on healthcare, and a move towards home healthcare—where light tubing is needed by portable medical devices—helps to fuel the market. The cumulative effect of population aging, the need for minimally invasive surgery, advances in technology, and compliance with regulations helps maintain a growth momentum in the medical tubing market as evolving global healthcare demands persist. Download PDF Brochure: Browse in-depth TOC on 'Medical Tubing Market' 238 - Market Data Tables 53 – Figures 252 - Pages List of Key Players in Medical Tubing Market: Saint-Gobain (France) Freudenberg Medical (US) W. L. Gore & Associates, Inc. (US) The Lubrizol Corporation (US) Nordson Corporation (US) TE Connectivity (Switzerland) Elkem ASA (Norway) Trelleborg AB (Sweden) RAUMEDIC AG (Germany) Teknor Apex (US) Spectrum Plastics Group (US) Zeus Company LLC (US) Drivers, Opportunities and Challenges in Medical Tubing Market: Drivers: Increasing demand for minimally invasive medical procedures Restraint: Limited material compatibility Opportunity: Increasing governmental expenditure for upgrading and developing healthcare infrastructure Challenge: High cost of producing and marketing medical tubing products Get Sample Pages: Key Findings of the Study: Rubber has the largest market share in the medical tubing market during the forecast period. Catheters & cannulas holds the largest share in the medical tubing market during forecast period. In terms of structure, multi-lumen holds the largest share in the medical tubing market during forecast period. North America to be the largest market during the forecast period. Smart tubing in healthcare application are the new advanced tubing systems that have sensors, conductive components, or microfluidic channels integrated into them for enhanced functionality, security, and monitoring. Such tubes are beyond the mere transportation of fluid as they consist of real-time data collection, automation, and enhanced control features, which provide better patient care and procedural efficiency. One of the important features of smart tubing is intrinsic sensors that track parameters such as pressure, temperature, and flow rate to achieve optimal performance in applications like intravenous (IV) therapy, dialysis, and catheterization. Real-time monitoring ensures detection of blockages, leaks, or aberrations, minimizing complications. Certain smart tubing systems also feature RFID or Bluetooth technology for wireless data communication, facilitating remote monitoring in hospital and home healthcare environments. Specialty polymers are growing fastest in the medical tubing market due to their exceptional performance properties, which address the changing demands of the healthcare market. These include thermoplastic elastomers (TPE), polyether ether ketone (PEEK), and fluoropolymers. They provide increased biocompatibility, chemical resistance, and abrasion resistance compared to traditional rubbers and plastics. Their resistance to aggressive sterilization methods, such as autoclaving and gamma radiation, also makes them suitable for use in applications that demand high standards of hygiene, e.g., catheters, intravenous (IV) tubing, and dialysis machines. The increasing demand for minimally invasive surgical procedures has also promoted the use of specialty polymers, as they allow for the creation of flexible, lightweight, and high-performance tubing. Their greater mechanical toughness ensures consistency in rigorous applications, reducing the risk of tube collapse and enhancing patient safety. Specialty polymers are also more resistant to drug interaction and biofouling, ensuring medical liquid integrity as it flows through the tubing. The increasing cases of chronic diseases, such as cardiovascular diseases and diabetes, are propelling higher demand for more advanced medical equipment, hence driving demand for specialty polymer tubing. The fast-paced progress in the field of material science has made it possible to design antimicrobial polymers, thus improving infection prevention in medical facilities. Regulatory bodies like the FDA and EU MDR have also mandated strict standards for medical materials, with a preference for high-performance polymers that are safe and sustainable. As medical device companies and healthcare providers look for materials with better functionality, durability, and regulatory compliance, specialty polymers continue to see accelerated uptake. Their distinct benefits over conventional materials, along with the increasing focus on innovation and patient-centered care, are propelling their highest growth in the medical tubing industry. Drug delivery systems are witnessing the most rapid expansion in the medical tubing industry due to changing healthcare requirements and technological innovation. The increasing incidence of chronic diseases requires effective and targeted drug delivery. Tubing is essential to these systems, allowing drug delivery directly to targeted locations within the body for increased efficacy with reduced side effects. This requirement is further fuelled by the aging population globally, which increasingly needs frequent and advanced medical therapy, much of which involves the use of drug-delivery tubing. In addition, ever-present innovation in drug delivery technology is a key driver. Breakthroughs such as injectable systems, insulin pumps, and inhalers are highly dependent on tailor-made medical tubing to operate efficiently. The evolution of minimally invasive drug delivery systems, including microneedle arrays or linked drug delivery devices, has boosted demand for specialized tubing that can meet complex specifications such as controlled release or high-viscosity biologics. Such innovations enhance patient compliance and comfort, further enhancing adoption. The trend towards personalized medicine drives this growth. Personalized treatments need flexible tubing solutions that can support customized drug formulations and delivery regimens, so drug delivery systems are a dynamic category. Partnerships between medical device and pharma companies are broadening the scope and application of these systems, fueling demand for premium, biocompatible tubing materials such as silicone and fluoropolymers. Get Customization on this Report: The medical tubing market offers various growth opportunities spurred by advances in healthcare technologies, surging demand for minimally invasive procedures, and the high incidence of chronic diseases. The greatest opportunity comes in the increasing usage of home healthcare and wearable medical devices like insulin pumps and portable oxygen therapy that need top-grade, flexible, and robust tubing. Moreover, the growing application of biologics generate a need for specialized tubing solutions that provide the safe and accurate delivery of sensitive drugs. Advances in material science, such as biodegradable and antimicrobial tubing, provide opportunities to improve patient safety and minimize hospital-acquired infections. The incorporation of intelligent technologies, including sensors on tubing for the real-time measurement of fluid flow and pressure, is another area with great promise, enhancing the accuracy and efficiency of treatment. Asian-Pacific and Latin America provide compelling opportunities for growth that are accompanied by building up health care infrastructures and further investments by the governments in the manufacture of medical devices. Additionally, the movement toward green and recyclable medical materials concurs with world environmental campaigns to support the design of green medical tubing. With ongoing needs for healthcare, on-going research and advancements in technology will create increased prospects for the medical tubing market. Saint-Gobain (France) is a French multinational corporation dedicated to industrial construction materials and services manufacturing and distribution. The medical tubing business segment operates under its subsidiary Saint-Gobain Performance Plastics which trades as Saint-Gobain Life Sciences. The division of Saint-Gobain Performance Plastics develops numerous high-performance materials and component products including medical tubing products for medical applications in healthcare sectors. Freudenberg Medical (US), a division of Germany-based Freudenberg Group, develops medical components and devices while also designing and manufacturing them. By operating under Freudenberg Group's specialties business area the company delivers catheters, hypotubes and balloons with minimally invasive procedure coating solutions alongside steerable shafts, engineered needles and precision-molded components and medical silicone and plastic tubing. Freudenberg Medical operates 11 manufacturing facilities through corporate branches located across the Americas, Europe and Asia servicing Costa Rica, India, China, Ireland, Singapore, the United States and Germany. Browse Adjacent Markets Specialty Chemicals Market Research Reports & Consulting Related Reports: Chillers Market Lubricants Market Global Chemical Industry Outlook 2025 Wood Coatings Market Cooling Fabrics Market CONTACT: About MarketsandMarkets™ MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter, LinkedIn and Facebook. Contact: Mr. Rohan Salgarkar MarketsandMarkets™ INC. 1615 South Congress Ave. Suite 103, Delray Beach, FL 33445, USA: +1-888-600-6441 Email: sales@ Visit Our Website: in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
6 minutes ago
- Yahoo
2 Big Reasons the 2026 Social Security COLA Might Not Be Enough
Key Points The latest estimates call for a 2026 COLA of 2.7%, although we won't know for sure until October. The inflation metric used to calculate the COLA isn't doing a great job of tracking expenses on older Americans. Medicare Part B premium increases could consume a large portion of the COLA. The $23,760 Social Security bonus most retirees completely overlook › After the July inflation data was released, the latest estimates from the Senior Citizens League are calling for a Social Security cost-of-living adjustment, or COLA, of 2.7% for beneficiaries in 2026. This is one-tenth of one percentage point greater than the prior estimate and would be a raise from the 2.5% COLA that went into effect this year. Social Security COLAs help retirees and other beneficiaries keep up with the rising costs of goods and services. And while a higher estimated COLA might sound like good news, there are a couple of good reasons it might not be enough. Here's what all retirees and other Social Security beneficiaries should know. Medicare premiums could consume a lot of the COLA The first reason the 2026 COLA might not be enough is Medicare premiums. Specifically, Social Security beneficiaries who are over 65 and enrolled in Medicare typically pay their Medicare Part B premiums directly from their Social Security checks. Here's the key point. Although the COLA is expected to add 2.7% to Social Security benefits, Medicare Part B premiums are expected to rise by 11.6%, from $185 per month this year to $206.50 per month in 2026. The average retired worker would get a $54 monthly increase from a 2.7% COLA. However, $21.50 of this would be consumed by Medicare premium increases. This would make the effective increase $33.50 per month that can be used to help pay for living expenses. This isn't exactly a unique occurrence for 2026. Over the past five years, Social Security COLAs have produced a cumulative increase of about 23% for beneficiaries. In the same period, Medicare Part B premiums have risen by 28%, consuming more and more of the Social Security checks of Medicare beneficiaries. The CPI-W isn't the best inflation metric for the elderly When calculating the Social Security COLA, the inflation metric that is used is a variation of the consumer price index called the CPI-W. This increased by 2.5% year over year in July and is intended to measure inflation as it affects workers. This creates an obvious issue -- most Social Security beneficiaries are retired, and different goods and services affect them differently. There's another metric called the CPI-E that is specifically designed to measure the effects of inflation on the elderly. Just to name a couple examples, seniors tend to spend a greater portion of their income on healthcare and housing than the average American household. In July, the year-over-year inflation rate for outpatient hospital services was 6.4%. Housing costs have increased by 3.7% over the past year. Overall, the CPI-E increased by 2.9% year over year in July, 0.4% more than the CPI-W. When will we know the 2026 Social Security COLA for sure? As it stands, because of a combination of expected Medicare premium increases and senior-specific costs rising faster than the Social Security Administration's preferred inflation metric, the COLA might not do its intended job of helping seniors keep up with the cost of living. As a final point, it's important to realize that we don't know for sure what the COLA will be for 2026. It's based on third-quarter CPI-W data (July, August, and September), and we've only seen one of those monthly reports so far. We'll know for sure how much of a raise seniors will get when finalized third quarter inflation data is available in mid-October. The $23,760 Social Security bonus most retirees completely overlook If you're like most Americans, you're a few years (or more) behind on your retirement savings. But a handful of little-known could help ensure a boost in your retirement income. One easy trick could pay you as much as $23,760 more... each year! Once you learn how to maximize your Social Security benefits, we think you could retire confidently with the peace of mind we're all after. Join Stock Advisor to learn more about these Motley Fool has a disclosure policy. 2 Big Reasons the 2026 Social Security COLA Might Not Be Enough was originally published by The Motley Fool Melden Sie sich an, um Ihr Portfolio aufzurufen.
